DEF 14A: Constellation Seeks SPAC Extension to January 2027

Constellation Acquisition Corp I seeks shareholder approval to extend its business combination deadline to February 28, 2026, with monthly extensions possible until January 29, 2027, to finalize a potential deal with HiTech Minerals.

Summary

• Constellation Acquisition Corp I (a SPAC) is holding an extraordinary general meeting on January 27, 2026, to vote on extending its deadline to complete a Business Combination.
• The proposed Extension Amendment Proposal would move the termination date from January 29, 2026, to February 28, 2026.
• The company could then elect to extend the deadline monthly for up to eleven additional months, reaching a final termination date of January 29, 2027, without further shareholder votes.
• For each monthly extension, the Sponsor (or its affiliates) will deposit $5,000 into the Trust Account, in exchange for a non-interest bearing, unsecured promissory note. The total potential deposit for extensions is up to $55,000.
• Public shareholders have the right to redeem their Class A Ordinary Shares for cash, regardless of their vote on the extension. As of January 12, 2026, the redemption price was approximately $13.37 per share, while the market price on January 14, 2026, was $12.99.
• The company has a non-binding term sheet for a business combination with HiTech Minerals, Inc., a subsidiary of Jindalee Lithium Limited, but no definitive agreement has been reached.
• The Sponsor, holding approximately 97.7% of the outstanding Ordinary Shares, intends to vote in favor of the extension and adjournment proposals, effectively ensuring their approval.
• If the extension is not approved and a Business Combination is not completed by January 29, 2026, the company will liquidate, and warrants will expire worthless.

Sentiment

Score: 3

Explanation: The company is in a precarious position, having sought multiple extensions and experienced significant redemptions, leading to a substantially depleted Trust Account and delisting from NYSE. While the extension provides a lifeline and a non-binding term sheet exists, the history of delays and the current market valuation below redemption price indicate considerable challenges and a high risk of liquidation. The Sponsor's continued financial support is a positive, but it comes with significant personal interests.

Positives

• The proposed extension provides additional time for Constellation to complete a Business Combination, potentially avoiding liquidation.
• A non-binding term sheet is in place with HiTech Minerals, Inc., indicating progress towards a potential acquisition.
• Public shareholders have the option to redeem their shares at a price ($13.37 as of January 12, 2026) higher than the current market price ($12.99 as of January 14, 2026), offering a guaranteed return for those who redeem.
• The Sponsor's commitment to fund monthly extensions (up to $55,000) demonstrates continued support for finding a Business Combination.

Negatives

• The company has already sought and received multiple extensions (First, Second, and Third Extension Meetings), indicating persistent difficulty in securing a Business Combination.
• Significant redemptions have occurred in previous extension votes, reducing the Trust Account balance from $310,000,000 initially to approximately $860,165 as of January 12, 2026.
• The company voluntarily delisted from NYSE on January 16, 2024, and now trades on the OTCID, which can lead to reduced liquidity, limited market quotations, and potential 'penny stock' designation.
• The non-binding term sheet with HiTech Minerals, Inc. does not guarantee a definitive agreement or successful Business Combination.
• Warrants will expire worthless if the company liquidates, impacting warrant holders.
• The Trust Account funds are now held in a cash demand deposit account with a variable interest rate (approximately 2.75% per annum), which is likely lower than previous investments in U.S. government treasury obligations, reducing potential interest income.
• The Sponsor and management have significant financial interests in completing a Business Combination, which may differ from public shareholders' interests.

Risks

• No assurance that the Articles Extension will enable the company to complete a Business Combination.
• The ability to consummate any Business Combination is dependent on factors beyond the company's control.
• Large redemptions by public shareholders could adversely affect the liquidity and trading of securities and leave insufficient cash to consummate a Business Combination on commercially acceptable terms.
• Inability to sell Class A Ordinary Shares in the open market due to insufficient liquidity, especially if the market price is lower than the redemption price.
• Significant material adverse consequences due to trading on the over-the-counter market, including limited market quotations, reduced liquidity, potential 'penny stock' designation, decreased ability to issue additional securities or obtain financing, and being a less attractive acquisition vehicle.
• Changes to laws or regulations (e.g., 2024 SPAC Rules) or their interpretation/application may adversely affect the business, including the ability to complete a Business Combination.
• Risk of being deemed an investment company under the Investment Company Act of 1940, which would impose burdensome compliance requirements and severely restrict activities, potentially leading to liquidation.
• Potential regulatory review by the Committee on Foreign Investment in the United States (CFIUS) if non-U.S. persons are involved in a Business Combination, which could block, delay, or impose conditions on the transaction.
• If the company liquidates, public shareholders may receive less than $10.00 per share if claims of creditors or third parties (without waivers) reduce the Trust Account balance.
• Warrants will expire worthless if the company dissolves and liquidates the Trust Account.
• The Sponsor's promissory notes will only be repaid from funds held outside of the Trust Account or will be forfeited if a Business Combination is not completed.
• The company believes it will not be able to complete a Business Combination by the current termination date (January 29, 2026) without the extension, leading to forced liquidation.

Future Outlook

The company intends to continue seeking a Business Combination until the extended termination date of January 29, 2027, if all monthly extensions are utilized. If the Extension Amendment Proposal is approved, the company will remain a reporting company under the Exchange Act, and its Class A Ordinary Shares and Public Warrants will continue to be publicly traded. If a Business Combination is consummated, the next annual meeting will be held at a future date determined by the post-Business Combination company. If no Business Combination is completed, the company will dissolve and liquidate.

Management Comments

• The Board of Constellation believes that it is in the best interests of Constellation that Constellation obtain the Articles Extension.
• Without the Articles Extension, Constellation believes that Constellation will not be able to complete a Business Combination on or before the Termination Date. If that were to occur, Constellation would be precluded from completing a Business Combination and would be forced to liquidate.
• Constellation cannot assure shareholders that they will be able to sell their Class A Ordinary Shares in the open market, even if the market price per share is lower than the redemption price stated above, as there may not be sufficient liquidity in its Securities when such shareholders wish to sell their shares.
• Constellation believes that such redemption right enables its public shareholders to determine whether to sustain their investments for an additional period if Constellation does not complete a Business Combination on or before the Termination Date.
• Constellation does not currently anticipate seeking any further extension to consummate a Business Combination, but may do so in the future.

Industry Context

This filing reflects the ongoing challenges faced by Special Purpose Acquisition Companies (SPACs) in identifying and completing suitable business combinations within their initial deadlines. The repeated need for extensions and the significant redemptions in prior extension votes are common themes in the current SPAC market, particularly following increased regulatory scrutiny, such as the SEC's 2024 SPAC Rules. The voluntary delisting from a major exchange (NYSE) to the over-the-counter market further highlights the difficulties and reduced investor interest in SPACs that struggle to complete deals. The shift of Trust Account funds from government securities to cash also indicates a response to regulatory concerns about SPACs potentially being deemed unregistered investment companies.

Comparison to Industry Standards

• The repeated need for extensions (this being the fourth extension request) is below industry standards for successful SPACs, which typically complete a business combination within their initial timeframe or one extension.
• The significant redemptions in previous extension votes (over $320 million redeemed across three prior extensions) indicate a lack of confidence from public shareholders in the company's ability to find a compelling target, contrasting with SPACs that maintain high trust account balances.
• The voluntary delisting from NYSE to OTCID is a negative deviation from industry standards, as most SPACs aim for listing on major exchanges to provide liquidity and investor visibility.
• The current redemption price of $13.37 per share being higher than the market price of $12.99 suggests that the market values the company's shares below their liquidation value, which is a common characteristic of SPACs nearing their termination date without a definitive deal.

Corporate Governance

Related Party Transactions

• The Sponsor (Constellation Sponsor LP) and its affiliates are the Lenders for the promissory notes used to fund Trust Account deposits for extensions.
• The Sponsor holds 7,633,750 Ordinary Shares and 5,466,667 Private Placement Warrants, which would be worthless upon liquidation, creating a strong incentive for the Sponsor to approve the extension and complete a Business Combination.
• The Sponsor has provided unsecured promissory notes totaling approximately $5.3 million to the company, with up to $1,270,000 convertible into warrants at $1.50 per warrant upon a Business Combination.
• The Sponsor has agreed to indemnify Constellation to ensure Trust Account proceeds are not reduced below $10.00 per Public Share by certain third-party claims.
• Constellation's officers and directors are members of the Sponsor and thus have indirect financial interests in the extension and completion of a Business Combination.

Stakeholder Impact

• Shareholders (Public): Face a decision to redeem shares for a price higher than market value or hold for potential upside from a Business Combination, which carries significant risk given past delays and redemptions. Their percentage interest may increase if redemptions occur.
• Shareholders (Sponsor/Initial): Have a strong incentive to approve the extension to protect their substantial investment in warrants and founder shares, which would be worthless upon liquidation. Their voting power (97.7%) ensures the proposals will pass.
• Warrant Holders: Warrants will expire worthless if the company liquidates, making the extension crucial for their potential value.
• Potential Target Business (HiTech Minerals, Inc.): The extension provides more time for the non-binding term sheet to potentially evolve into a definitive business combination agreement.
• Creditors: The company has obligations under Cayman Islands law to provide for claims of creditors in case of liquidation. The Sponsor's indemnification agreement offers some protection against claims reducing the Trust Account below a certain threshold.

Next Steps

• Hold an Extraordinary General Meeting on January 27, 2026, to vote on the Extension Amendment Proposal and Adjournment Proposal.
• If the Extension Amendment Proposal is approved, the company will continue efforts to consummate a Business Combination by February 28, 2026, or by January 29, 2027, if monthly extensions are utilized.
• If the Extension Amendment Proposal is approved and the Articles Extension becomes effective, the Sponsor (or Lender) will deposit $5,000 into the Trust Account within ten business days of the Shareholder Meeting.
• If a Business Combination is consummated, the company will hold another extraordinary general meeting to consider and vote upon the business combination agreement.
• If the Extension Amendment Proposal is not approved, or if a Business Combination is not completed by the termination date, the company will cease operations, redeem Public Shares, and liquidate.

Key Dates

Recommendation

Given the company's history of multiple extensions, significant prior redemptions, and voluntary delisting to the OTC market, the risk profile is very high. The current market price is below the redemption value, offering public shareholders a clear opportunity to exit at a premium to the market. While a non-binding term sheet exists, the repeated delays and the company's precarious financial position (low Trust Account balance after redemptions) make the successful completion of a value-accretive Business Combination highly uncertain. The Sponsor's overwhelming voting power and strong personal incentives to complete a deal may not align with maximizing returns for public shareholders who choose not to redeem. Investors should consider taking the redemption value rather than holding shares with high uncertainty and limited liquidity.

Keywords

SPAC, Business Combination, Extension, Proxy Statement, Redemption Rights, Trust Account, Constellation Acquisition Corp I, Jindalee Lithium, HiTech Minerals, OTC Market, Liquidation, Warrants, SEC Filing, Corporate Governance, Investment Company Act